Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 284

1.

[Zika virus, an emerging threat].

Salinas S, Foulongne V, Loustalot F, Fournier-Wirth C, Molès JP, Briant L, Nagot N, Van de Perre P, Simonin Y.

Med Sci (Paris). 2016 Apr;32(4):378-86. doi: 10.1051/medsci/20163204016. Epub 2016 May 2. French.

PMID:
27137695
2.

Fecal Carriage of Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamases in Hospitalized Patients and Healthy Community Volunteers in Burkina Faso.

Ouédraogo AS, Sanou S, Kissou A, Poda A, Aberkane S, Bouzinbi N, Nacro B, Ouédraogo R, Van De Perre P, Carriere C, Decré D, Jean-Pierre H, Godreuil S.

Microb Drug Resist. 2016 Apr 19. [Epub ahead of print]

PMID:
27092971
3.

Association between breast milk fatty acids and HIV-1 transmission through breastfeeding.

Badiou S, Tuaillon E, Viljoen J, Escudié JB, Cristol JP, Newell ML, Van de Perre P, Neveu D.

Prostaglandins Leukot Essent Fatty Acids. 2016 Feb;105:35-42. doi: 10.1016/j.plefa.2015.11.004. Epub 2015 Dec 28.

PMID:
26869089
4.

HIV risk and behaviour among part-time versus professional FSW: baseline report of an interventional cohort in Burkina Faso.

Traore IT, Hema NM, Sanon A, Some F, Ouedraogo D, Some R, Niessougou J, Konate I, Mayaud P, Van De Perre P, Meda N, Nagot N.

Sex Transm Infect. 2016 Feb 1. pii: sextrans-2015-052038. doi: 10.1136/sextrans-2015-052038. [Epub ahead of print]

PMID:
26834073
5.

Cytokine Response Associated with Hepatitis C Virus Clearance in HIV Coinfected Patients Initiating Peg Interferon-α Based Therapy.

Nguyen TT, Niloofar R, Rubbo PA, Nils K, Bollore K, Ducos J, Pageaux GP, Reynes J, Van de Perre P, Tuaillon E.

Mediterr J Hematol Infect Dis. 2016 Jan 1;8(1):e2016003. doi: 10.4084/MJHID.2016.003. eCollection 2016.

6.

Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.

Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Maréchal V, Neveu D, Engebretsen IM, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskär T, Van de Perre P; ANRS 12174 Trial Group.

Lancet. 2016 Feb 6;387(10018):566-73. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19.

PMID:
26603917
7.

Herpes Simplex Virus Type-2 Cervicovaginal Shedding Among Women Living With HIV-1 and Receiving Antiretroviral Therapy in Burkina Faso: An 8-Year Longitudinal Study.

Low AJ, Nagot N, Weiss HA, Konate I, Kania D, Segondy M, Meda N, van de Perre P, Mayaud P; Yerelon Study Group.

J Infect Dis. 2016 Mar 1;213(5):731-7. doi: 10.1093/infdis/jiv495. Epub 2015 Oct 15.

8.

HIV prevention and care services for female sex workers: efficacy of a targeted community-based intervention in Burkina Faso.

Traore IT, Meda N, Hema NM, Ouedraogo D, Some F, Some R, Niessougou J, Sanon A, Konate I, Van De Perre P, Mayaud P, Nagot N.

J Int AIDS Soc. 2015 Sep 14;18:20088. doi: 10.7448/IAS.18.1.20088. eCollection 2015.

9.

Ebola virus vaccine: benefit and risks of adenovirus-based vectors.

Mennechet FJ, Tran TT, Eichholz K, van de Perre P, Kremer EJ.

Expert Rev Vaccines. 2015 Nov;14(11):1471-8. doi: 10.1586/14760584.2015.1083429. Epub 2015 Aug 31.

PMID:
26325242
10.

High Level of HBV DNA Virus in the Breast Milk Seems not to Contraindicate Breastfeeding.

Montoya-Ferrer A, Zorrilla AM, Viljoen J, Molès JP, Newell ML, Van de Perre P, Tuaillon E.

Mediterr J Hematol Infect Dis. 2015 Jul 1;7(1):e2015042. doi: 10.4084/MJHID.2015.042. eCollection 2015. No abstract available.

11.

Evidence of long-lived founder virus in mother-to-child HIV transmission.

Danaviah S, de Oliveira T, Bland R, Viljoen J, Pillay S, Tuaillon E, Van de Perre P, Newell ML.

PLoS One. 2015 Mar 20;10(3):e0120389. doi: 10.1371/journal.pone.0120389. eCollection 2015.

12.

Montpellier Infectious Diseases - Pôle Rabelais (MID) 3rd annual meeting (2014).

Besteiro S, Blanc-Potard A, Bonazzi M, Briant L, Chazal N, Cornillot E, Lentini G, Matkovic R, Sanosyan A, Tuaillon E, Van de Perre P.

Infect Genet Evol. 2015 Jun;32:161-4. doi: 10.1016/j.meegid.2015.03.007. Epub 2015 Mar 16.

PMID:
25791932
13.

Ebola vaccines based on adenovirus vectors and risk of HIV.

Kremer EJ, Van de Perre P.

BMJ. 2015 Mar 10;350:h1307. doi: 10.1136/bmj.h1307. No abstract available.

PMID:
25757599
14.

Early infant feeding patterns and HIV-free survival: findings from the Kesho-Bora trial (Burkina Faso, Kenya, South Africa).

Cournil A, Van de Perre P, Cames C, de Vincenzi I, Read JS, Luchters S, Meda N, Naidu K, Newell ML, Bork K; Kesho Bora Study Group.

Pediatr Infect Dis J. 2015 Feb;34(2):168-74. doi: 10.1097/INF.0000000000000512.

PMID:
25741969
15.

Potential impact of existing interventions and of antiretroviral use in female sex workers on transmission of HIV in Burkina Faso: a modeling study.

Low A, Nagot N, Konate I, Meda N, Segondy M, Van de Perre P, Mayaud P, Vickerman P.

J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S180-8. doi: 10.1097/QAI.0000000000000441.

PMID:
25723983
16.

Developmental determinants in non-communicable chronic diseases and ageing.

Bousquet J, Anto JM, Berkouk K, Gergen P, Antunes JP, Augé P, Camuzat T, Bringer J, Mercier J, Best N, Bourret R, Akdis M, Arshad SH, Bedbrook A, Berr C, Bush A, Cavalli G, Charles MA, Clavel-Chapelon F, Gillman M, Gold DR, Goldberg M, Holloway JW, Iozzo P, Jacquemin S, Jeandel C, Kauffmann F, Keil T, Koppelman GH, Krauss-Etschmann S, Kuh D, Lehmann S, Carlsen KC, Maier D, Méchali M, Melén E, Moatti JP, Momas I, Nérin P, Postma DS, Ritchie K, Robine JM, Samolinski B, Siroux V, Slagboom PE, Smit HA, Sunyer J, Valenta R, Van de Perre P, Verdier JM, Vrijheid M, Wickman M, Yiallouros P, Zins M.

Thorax. 2015 Jun;70(6):595-7. doi: 10.1136/thoraxjnl-2014-206304. Epub 2015 Jan 23.

17.

Cytomegalovirus, and possibly Epstein-Barr virus, shedding in breast milk is associated with HIV-1 transmission by breastfeeding.

Viljoen J, Tuaillon E, Nagot N, Danaviah S, Peries M, Padayachee P, Foulongne V, Bland R, Rollins N, Newell ML, van de Perre P.

AIDS. 2015 Jan 14;29(2):145-53. doi: 10.1097/QAD.0000000000000527.

PMID:
25535751
18.

Performances of fourth generation HIV antigen/antibody assays on filter paper for detection of early HIV infections.

Kania D, Truong TN, Montoya A, Nagot N, Van de Perre P, Tuaillon E.

J Clin Virol. 2015 Jan;62:92-7. doi: 10.1016/j.jcv.2014.11.005. Epub 2014 Nov 13.

PMID:
25464967
19.

Missed opportunities for early access to care of HIV-infected infants in Burkina Faso.

Coulibaly M, Meda N, Yonaba C, Ouedraogo S, Congo M, Barry M, Thio E, Siribié I, Koueta F, Ye D, Kam L, Blanche S, Van De Perre P, Leroy V; MONOD Study Group ANRS 12206.

PLoS One. 2014 Oct 31;9(10):e111240. doi: 10.1371/journal.pone.0111240. eCollection 2014.

20.

Mycobacterium bovis in Burkina Faso: epidemiologic and genetic links between human and cattle isolates.

Sanou A, Tarnagda Z, Kanyala E, Zingué D, Nouctara M, Ganamé Z, Combary A, Hien H, Dembele M, Kabore A, Meda N, Van de Perre P, Neveu D, Bañuls AL, Godreuil S.

PLoS Negl Trop Dis. 2014 Oct 2;8(10):e3142. doi: 10.1371/journal.pntd.0003142. eCollection 2014 Oct.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk